Memory loss, confusion, cognitive impairment, and brain inflammation. Those aren’t just the signs and symptoms of Alzheimer’s disease and dementia. A year after a…
At Being Patient, we host regular LiveTalks with experts, advocates and people living with Alzheimer’s and dementia as a part of our mission to…
Professor Lili Liu and postdoctoral fellow Hector Perez at the University of Waterloo School of Public Health Sciences discuss how to prevent missing person…
UPDATE: 3 March 2024, 8:16 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Update: As of July 6, 2023, the drug has full, traditional FDA approval. Today, the Food and Drug Administration approved Leqembi (generic name lecanemab), a…
An Offer He Couldn’t Refuse: Reporter Phil Gutis interviews Joanne Pike on her first day as CEO of the Alzheimer’s Association As any reporter…
Drugmakers Eisai and Biogen took their anti-amyloid Alzheimer’s treatment, lecanemab, to the finish line. By clearing amyloid plaques in the brains of people with…
University of Birmingham neurology fellow and dreams researcher Abidemi Otaiku discusses his new findings that people with Parkinson’s disease have nightmares as much as…
Almost 400,000 Australians are living with dementia. A million or more family members and friends care for and support them. About two-thirds of people…
The connections between the neurons in your brain enable you to do amazing things, from brushing your teeth to solving calculus equations. When these…
As part of our mission to bring you trustworthy information that’s easy to understand, our editorial team hosts weekly LiveTalks with experts, advocates and…
Game of Thrones star Emilia Clarke is missing ‘quite a bit’ of her brain. How can people survive and thrive after brain injury? In a…
Lecanemab, Eisai and Biogen’s experimental anti-amyloid Alzheimer’s drug, which recently wrapped its Phase 3 clinical trials, continues to make the news. Some of these…
The prevalence of dementia is rising globally — and efforts to fight the stigma around dementia are on the rise, too. In the Netherlands, elementary…
A few months before Jasja De Smedt Kotterman’s mother died of Alzheimer’s at age 76, Kotterman found her mother staring vacantly at a meal,…